{"url":"https://etfiq.com/compare/income/bioy-vs-wepn","section":"compare","title":"BIOY vs WEPN: Dividend Yield & Total Return | ETFIQ","description":"BIOY paid 26.1% in cash each over its own window and WEPN 7.4%. Total return with distributions reinvested was +5.4% against \u221217.8%, to Nov 4, 2026.","as_of":"Nov 4, 2026","structured_data":[{"@type":"FAQPage","mainEntity":[{"@type":"Question","name":"Which is cheaper, BIOY or WEPN?","acceptedAnswer":{"@type":"Answer","text":"BIOY charges 1.18% a year and WEPN charges 1.11%, so WEPN is cheaper. Fees come from each fund's prospectus."}}]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"ETFIQ","item":"https://etfiq.com/"},{"@type":"ListItem","position":2,"name":"Income ETFs","item":"https://etfiq.com/income/"},{"@type":"ListItem","position":3,"name":"Compare ETFs","item":"https://etfiq.com/compare/"},{"@type":"ListItem","position":4,"name":"BIOY vs WEPN","item":"https://etfiq.com/compare/income/bioy-vs-wepn"}]},{"@type":"WebPage","name":"BIOY vs WEPN: Dividend Yield & Total Return","description":"BIOY paid 26.1% in cash each over its own window and WEPN 7.4%. Total return with distributions reinvested was +5.4% against \u221217.8%, to Nov 4, 2026.","url":"https://etfiq.com/compare/income/bioy-vs-wepn","dateModified":"2026-11-04","abstract":"BIOY and WEPN both write options for income.","publisher":{"@id":"https://etfiq.com/#org"},"isPartOf":{"@id":"https://etfiq.com/#website"},"speakable":{"@type":"SpeakableSpecification","cssSelector":[".verdict",".faq"]}},{"@type":"Dataset","name":"ETFIQ comparison of BIOY and WEPN","description":"BIOY paid 26.1% in cash each over its own window and WEPN 7.4%. Total return with distributions reinvested was +5.4% against \u221217.8%, to Nov 4, 2026.","dateModified":"2026-11-04","creator":{"@id":"https://etfiq.com/#org"},"isAccessibleForFree":true,"url":"https://etfiq.com/compare/income/bioy-vs-wepn","license":"https://etfiq.com/license/","publisher":{"@id":"https://etfiq.com/#org"},"inLanguage":"en","creativeWorkStatus":"Published","distribution":[{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/income.json"}],"variableMeasured":["Cash paid","Price change","Total return with distributions reinvested","Benchmark total return","Ahead or behind in percentage points","Distribution rate","Return of capital estimate","Expense ratio"],"keywords":["exchange-traded funds","ETF","Income ETFs","fund data","SEC filings"]}],"characters":6526,"truncated":true,"content":"ETFIQ / Income ETFs / Compare ETFs / BIOY vs WEPN \n ETFIQ etfiq.com \u00b7 independent ETF data \n\n Data as of Nov 4, 2026 .\n\n BIOY vs WEPN: Dividend Yield & Total Return\n\n BIOY and WEPN both write options for income.\n Copy this for sharing \n \n WEPN costs 0.07 points a year less.\n BIOY and WEPN at a glance. As of Nov 4, 2026. Source: ETFIQ. BIOY WEPN \n Expense ratio 1.18% 1.11% \n Net assets, BIOY as of Nov 3, 2026 and WEPN as of Jul 31, 2026 $1.5m $6.1m \n Benchmark Biotech, measured through XBI its own holdings \n Holdings in common 0% \n Holdings in common uses holdings dated Jun 30, 2026 and Jul 31,","source":"ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.","publisher":{"@id":"https://etfiq.com/#org","name":"ETFIQ","url":"https://etfiq.com"},"license":"https://etfiq.com/license/","license_text":"Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.","citation":"ETFIQ, BIOY against WEPN, data as of Nov 4, 2026. https://etfiq.com/compare/income/bioy-vs-wepn","a":{"ticker":"BIOY","name":"GraniteShares YieldBOOST Biotech ETF","issuer":"GraniteShares","desk":"income","as_of":"2026-11-04","verdict":"Since launch in May 2026, BIOY paid 26.1% in cash and returned 5.4% in total, against 19.0% for XBI.","url":"https://etfiq.com/funds/bioy","key_facts":[{"label":"Cash paid, since launch, on its starting price","value":"26.1%","as_of":"2026-11-04","source":"computed by ETFIQ from Tiingo daily prices and distributions"},{"label":"Total return, since launch","value":"+5.4%","as_of":"2026-11-04","source":"computed by ETFIQ from Tiingo daily prices"},{"label":"Against XBI","value":"\u221213.6 pts","as_of":"2026-11-04","source":"computed by ETFIQ from Tiingo daily prices"},{"label":"Return of capital, latest payout (GraniteShares estimate)","value":"96.3%","as_of":"2026-11-04","source":"GraniteShares estimate"},{"label":"Last payment (paid weekly), ex-date Oct 30, 2026","value":"$0.2279","as_of":"2026-10-30","source":"Tiingo end-of-day distributions"},{"label":"Net assets","value":"$1.5m","as_of":"2026-11-03","source":"issuer page, as of Nov 3, 2026"},{"label":"Expense ratio","value":"1.18%","as_of":"2026-10-28","source":"497 XBRL, Oct 28, 2026"}]},"b":{"ticker":"WEPN","name":"Nicholas Defense and Rare Earth Income ETF","issuer":"Nicholas","desk":"income","as_of":"2026-11-04","verdict":"Over the 6 months to Nov 4, 2026, WEPN paid 5.8% in cash and lost 11.8%, against \u22125.9% for its own holdings.","url":"https://etfiq.com/funds/wepn","key_facts":[{"label":"Cash paid, 6 months, on its starting price","value":"5.8%","as_of":"2026-11-04","source":"computed by ETFIQ from Tiingo daily prices and distributions"},{"label":"Total return, 6 months","value":"\u221211.8%","as_of":"2026-11-04","source":"computed by ETFIQ from Tiingo daily prices"},{"label":"Against its own holdings","value":"\u22125.9 pts","as_of":"2026-11-04","source":"computed by ETFIQ from Tiingo daily prices"},{"label":"Return of capital, latest payout (Nicholas estimate)","value":"100.0%","as_of":"2026-11-04","source":"Nicholas estimate"},{"label":"Last payment (paid weekly), ex-date Nov 3, 2026","value":"$0.094","as_of":"2026-11-03","source":"Tiingo end-of-day distributions"},{"label":"Net assets","value":"$6.1m","as_of":"2026-07-31","source":"SEC filing, whole fund, as filed for Jul 31, 2026"},{"label":"Expense ratio","value":"1.11%","as_of":"2026-02-04","source":"485BPOS XBRL, Feb 4, 2026"}]},"overlap_pct":0,"full_text_at":"https://etfiq.com/compare/income/bioy-vs-wepn"}